# Study of Concomitant Administration of the sIPV and DTaP or MMR

> **NCT06920069** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 2640 (estimated)

## Conditions studied

- Polio
- Diphteria, Tetanus and Pertussis
- MMR Vaccine

## Interventions

- **BIOLOGICAL:** sIPV
- **BIOLOGICAL:** DTaP
- **BIOLOGICAL:** bOPV 1,3
- **BIOLOGICAL:** MMR Vaccine

## Key facts

- **NCT ID:** NCT06920069
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2030-07-15
- **Final completion:** 2031-06-15
- **Target enrollment:** 2640 (ESTIMATED)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920069, "Study of Concomitant Administration of the sIPV and DTaP or MMR". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06920069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*